QUARTERLY REPORT

Q1 2022 — Form 10-Q

Q1 2022PDF · 28 pages366 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the quarterly period ended March 31, 2022
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from ___________ to ___________
Commission File Number 001-03761
TEXAS INSTRUMENTS INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
Delaware 	75-0289970
(State of Incorporation) 	(I.R.S. Employer Identification No.)
12500 TI Boulevard, Dallas, Texas 	75243
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code 214-479-3773
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, par value $1.00 	TXN 	The Nasdaq Global Select Market
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was
required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
922,133,845
Number of shares of Registrant’s common stock outstanding as of
April 19, 2022

-- 1 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
PART I - FINANCIAL INFORMATION
ITEM 1. Financial statements
For Three Months Ended
Consolidated Statements of Income 	March 31,
(In millions, except per-share amounts) 	2022 	2021
Revenue 	$ 	4,905 $ 	4,289
Cost of revenue (COR) 	1,463 	1,492
Gross profit 	3,442 	2,797
Research and development (R&D) 	391 	386
Selling, general and administrative (SG&A) 	422 	425
Acquisition charges 	— 	47
Restructuring charges/other 	66 	—
Operating profit 	2,563 	1,939
Other income (expense), net (OI&E) 	15 	46
Interest and debt expense 	52 	46
Income before income taxes 	2,526 	1,939
Provision for income taxes 	325 	186
Net income 	$ 	2,201 $ 	1,753
Earnings per common share (EPS):
Basic 	$ 	2.37 $ 	1.89
Diluted 	$ 	2.35 $ 	1.87
Average shares outstanding:
Basic 	923 	922
Diluted 	934 	935
A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is
calculated using the following:
Net income 	$ 	2,201 $ 	1,753
Income allocated to RSUs 	(9) 	(8)
Income allocated to common stock for diluted EPS 	$ 	2,192 $ 	1,745
See accompanying notes.
2

-- 2 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
For Three Months Ended
Consolidated Statements of Comprehensive Income 	March 31,
(In millions) 	2022 	2021
Net income 	$ 	2,201 $ 	1,753
Other comprehensive income (loss)
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($2) and ($2) 	6 	5
Recognized within net income, net of tax effect of ($1) and ($3) 	2 	8
Available-for-sale investments:
Unrealized losses, net of tax effect of $1 and $0 	(4) 	—
Other comprehensive income (loss), net of taxes 	4 	13
Total comprehensive income 	$ 	2,205 $ 	1,766
See accompanying notes.
3

-- 3 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
March 31, 	December 31,
Consolidated Balance Sheets 	2022 	2021
(In millions, except par value)
Assets
Current assets:
Cash and cash equivalents 	$ 	3,505 $ 	4,631
Short-term investments 	6,320 	5,108
Accounts receivable, net of allowances of ($9) and ($8) 	1,795 	1,701
Raw materials 	265 	245
Work in process 	1,151 	1,067
Finished goods 	644 	598
Inventories 	2,060 	1,910
Prepaid expenses and other current assets 	330 	335
Total current assets 	14,010 	13,685
Property, plant and equipment at cost 	8,236 	7,858
Accumulated depreciation 	(2,797) 	(2,717)
Property, plant and equipment 	5,439 	5,141
Goodwill 	4,362 	4,362
Deferred tax assets 	273 	263
Capitalized software licenses 	91 	85
Overfunded retirement plans 	383 	392
Other long-term assets 	718 	748
Total assets 	$ 	25,276 $ 	24,676
Liabilities and stockholders’ equity
Current liabilities:
Current portion of long-term debt 	$ 	500 $ 	500
Accounts payable 	641 	571
Accrued compensation 	386 	775
Income taxes payable 	405 	121
Accrued expenses and other liabilities 	596 	602
Total current liabilities 	2,528 	2,569
Long-term debt 	7,242 	7,241
Underfunded retirement plans 	81 	79
Deferred tax liabilities 	94 	87
Other long-term liabilities 	1,314 	1,367
Total liabilities 	11,259 	11,343
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued 	— 	—
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741 	1,741 	1,741
Paid-in capital 	2,667 	2,630
Retained earnings 	47,053 	45,919
Treasury common stock at cost
Shares: March 31, 2022 – 819; December 31, 2021 – 817 	(37,291) 	(36,800)
Accumulated other comprehensive income (loss), net of taxes (AOCI) 	(153) 	(157)
Total stockholders’ equity 	14,017 	13,333
Total liabilities and stockholders’ equity 	$ 	25,276 $ 	24,676
See accompanying notes.
4

-- 4 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
For Three Months Ended
Consolidated Statements of Cash Flows 	March 31,
(In millions) 	2022 	2021
Cash flows from operating activities
Net income 	$ 	2,201 $ 	1,753
Adjustments to net income:
Depreciation 	200 	179
Amortization of acquisition-related intangibles 	— 	47
Amortization of capitalized software 	14 	15
Stock compensation 	74 	61
Gains on sales of assets 	(2) 	(1)
Deferred taxes 	(1) 	8
Increase (decrease) from changes in:
Accounts receivable 	(94) 	(170)
Inventories 	(150) 	65
Prepaid expenses and other current assets 	21 	73
Accounts payable and accrued expenses 	11 	69
Accrued compensation 	(388) 	(379)
Income taxes payable 	284 	131
Changes in funded status of retirement plans 	21 	28
Other 	(47) 	(29)
Cash flows from operating activities 	2,144 	1,850
Cash flows from investing activities
Capital expenditures 	(443) 	(308)
Proceeds from asset sales 	2 	1
Purchases of short-term investments 	(3,988) 	(2,782)
Proceeds from short-term investments 	2,774 	2,000
Other 	(13) 	(20)
Cash flows from investing activities 	(1,668) 	(1,109)
Cash flows from financing activities
Repayment of debt 	— 	(550)
Dividends paid 	(1,063) 	(940)
Stock repurchases 	(589) 	(100)
Proceeds from common stock transactions 	57 	196
Other 	(7) 	(12)
Cash flows from financing activities 	(1,602) 	(1,406)
Net change in cash and cash equivalents 	(1,126) 	(665)
Cash and cash equivalents at beginning of period 	4,631 	3,107
Cash and cash equivalents at end of period 	$ 	3,505 $ 	2,442
See accompanying notes.
5

-- 5 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Notes to financial statements
1. Description of business, including segment and geographic area information
We design, make and sell semiconductors to electronics designers and manufacturers all over the world. We have two reportable segments,
Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis of similar design and
development requirements, product characteristics, manufacturing processes and distribution channels.
• Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying
them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded
processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing,
discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog
segment consists of two major product lines: Power and Signal Chain.
• Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific
tasks and can be optimized for various combinations of performance, power and cost, depending on the application.
We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative
thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP products,
calculators and custom ASIC products.
Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating
segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit
basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not
provided.
Segment information
For Three Months Ended
March 31,
2022 	2021
Revenue:
Analog 	$ 	3,816 $ 	3,280
Embedded Processing 	782 	767
Other 	307 	242
Total revenue 	$ 	4,905 $ 	4,289
Operating profit:
Analog 	$ 	2,150 $ 	1,646
Embedded Processing 	315 	287
Other (a) 	98 	6
Total operating profit 	$ 	2,563 $ 	1,939
(a) Includes acquisition charges and restructuring charges/other
®
6

-- 6 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Geographic area information
The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information
does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers
manufacture their products.
For Three Months Ended
March 31,
2022 	2021
Revenue:
United States 	$ 	494 $ 	393
Asia (a) 	3,203 	2,858
Europe, Middle East and Africa 	814 	682
Japan 	263 	239
Rest of world 	131 	117
Total revenue 	$ 	4,905 $ 	4,289
(a) Revenue from products shipped into China was $2.5 billion and $2.3 billion in the first quarters of 2022 and 2021, respectively, which
includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as
distributors that transship inventory through China to service other countries.
2. Basis of presentation and significant accounting policies and practices
Basis of presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December
31, 2021. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended March 31, 2022 and
2021, and the Consolidated Balance Sheet as of March 31, 2022, are not audited but reflect all adjustments that are of a normal recurring
nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included
in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange
Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a
complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes
included in our annual report on Form 10-K for the year ended December 31, 2021. Certain amounts in prior periods' financial statements
have been reclassified to conform to the current presentation. The results for the three-month periods are not necessarily indicative of a full
year’s results.
Significant accounting policies and practices
Earnings per share (EPS)
We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing
non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded
from the calculation of income allocated to common stock.
7

-- 7 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Computation and reconciliation of earnings per common share are as follows:
For Three Months Ended March 31,
2022 	2021
Net Income 	Shares 	EPS 	Net Income 	Shares 	EPS
Basic EPS:
Net income 	$ 	2,201 	$ 	1,753
Income allocated to RSUs 	(9) 	(8)
Income allocated to common stock 	$ 	2,192 	923 $ 	2.37 $ 	1,745 	922 $ 	1.89
Dilutive effect of stock compensation plans 	11 	13
Diluted EPS:
Net income 	$ 	2,201 	$ 	1,753
Income allocated to RSUs 	(9) 	(8)
Income allocated to common stock 	$ 	2,192 	934 $ 	2.35 $ 	1,745 	935 $ 	1.87
Potentially dilutive securities representing 5 million and 3 million shares of common stock that were outstanding during the first quarters of
2022 and 2021, respectively, were excluded from the computation of diluted earnings per common share during these periods because their
effect would have been anti-dilutive.
Derivatives and hedging
We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign
currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have
on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency
exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.
We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total
return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the
swaps and the related deferred compensation liabilities in SG&A.
In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are
recognized in AOCI and amortized over the life of the related debt.
The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes.
Fair values of financial instruments
The fair values of our derivative financial instruments were not material as of March 31, 2022. Our investments in cash equivalents, short-
term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying
values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the
short maturity of such instruments. As of March 31, 2022, the carrying value of long-term debt, including the current portion, was
$7.74 billion, and the estimated fair value was $7.76 billion. The estimated fair value is measured using broker-dealer quotes, which are
Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.
3. Income taxes
Our estimated annual effective tax rate is about 14%, which does not include discrete tax items. This differs from the 21% U.S. statutory
corporate tax rate due to the effect of U.S. tax benefits.
8

-- 8 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Provision for income taxes is based on the following:
For Three Months Ended
March 31,
2022 	2021
Taxes calculated using the estimated annual effective tax rate 	$ 	361 	$ 	275
Discrete tax items 	(36) 	(89)
Provision for income taxes 	$ 	325 	$ 	186
Effective tax rate 	13 % 	10 %
4. Valuation of debt and equity investments and certain liabilities
Investments measured at fair value
Money market funds, available-for-sale debt investments and mutual funds are stated at fair value, which is generally based on market prices
or broker quotes. See Fair-value considerations. Unrealized gains and losses from available-for-sale debt securities are recorded as an
increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses on available-for-sale debt securities
are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.
Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred
compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.
Other investments
Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair
value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from
equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results.
Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses
on non-marketable equity investments are recognized in OI&E.
9

-- 9 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Details of our investments are as follows:
March 31, 2022 	December 31, 2021
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Measured at fair value:
Money market funds 	$ 	1,041 $ 	— $ 	— $ 	1,824 $ 	— $ 	—
Corporate obligations 	670 	1,104 	— 	1,060 	1,070 	—
U.S. government and agency securities 	846 	4,917 	— 	642 	3,388 	—
Non-U.S. government and agency
securities 	100 	299 	— 	300 	650 	—
Mutual funds 	— 	— 	13 	— 	— 	16
Total 	2,657 	6,320 	13 	3,826 	5,108 	16
Other measurement basis:
Equity-method investments 	— 	— 	33 	— 	— 	42
Non-marketable equity investments 	— 	— 	4 	— 	— 	4
Cash on hand 	848 	— 	— 	805 	— 	—
Total 	$ 	3,505 $ 	6,320 $ 	50 $ 	4,631 $ 	5,108 $ 	62
As of March 31, 2022, and December 31, 2021, unrealized gains and losses associated with our available-for-sale investments were not
material. We did not recognize any credit losses related to available-for-sale investments for the first three months of 2022 and 2021. All of
our debt securities classified as available for sale as of March 31, 2022, have maturities within one year.
Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $2.77 billion and $2.00 billion for the first
quarters of 2022 and 2021, respectively. Gross realized gains and losses from these sales were not material.
Fair-value considerations
We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in
an orderly transaction between market participants on the measurement date.
The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements.
• Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.
• Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation
with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not
active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require
significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by
readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for
reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in
active markets.
• Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management
judgment. These values are generally determined using pricing models that utilize management estimates of market participant
assumptions. As of March 31, 2022, and December 31, 2021, we had no Level 3 assets or liabilities.
10

-- 10 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on
hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.
March 31, 2022 	December 31, 2021
Level 1 	Level 2 	Total 	Level 1 	Level 2 	Total
Assets:
Money market funds 	$ 	1,041 $ 	— $ 	1,041 $ 	1,824 $ 	— $ 	1,824
Corporate obligations 	— 	1,774 	1,774 	— 	2,130 	2,130
U.S. government and agency securities 	5,413 	350 	5,763 	3,629 	401 	4,030
Non-U.S. government and agency securities 	— 	399 	399 	— 	950 	950
Mutual funds 	13 	— 	13 	16 	— 	16
Total assets 	$ 	6,467 $ 	2,523 $ 	8,990 $ 	5,469 $ 	3,481 $ 	8,950
Liabilities:
Deferred compensation 	$ 	350 $ 	— $ 	350 $ 	395 $ 	— $ 	395
Total liabilities 	$ 	350 $ 	— $ 	350 $ 	395 $ 	— $ 	395
5. Postretirement benefit plans
Expenses related to defined benefit and retiree health care benefit plans are as follows:
U.S. Defined Benefit 	U.S. Retiree Health Care 	Non-U.S. Defined Benefit
For Three Months Ended March 31, 	2022 	2021 	2022 	2021 	2022 	2021
Service cost 	$ 	4 $ 	5 $ 	1 $ 	1 $ 	7 $ 	9
Interest cost 	6 	8 	3 	3 	10 	9
Expected return on plan assets 	(8) 	(8) 	(4) 	(3) 	(18) 	(20)
Recognized net actuarial loss 	— 	4 	— 	— 	— 	2
Net periodic benefit costs 	2 	9 	— 	1 	(1) 	—
Settlement losses 	2 	4 	— 	— 	1 	1
Total, including other postretirement losses 	$ 	4 $ 	13 $ 	— $ 	1 $ 	— $ 	1
6. Debt and lines of credit
Short-term borrowings
We maintain a line of credit to support commercial paper borrowings, if any, and to provide additional liquidity through bank loans. As of
March 31, 2022, we had a variable-rate revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to
$1 billion until March 2023. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable Term Secured
Overnight Financing Rate (Term SOFR). As of March 31, 2022, our credit facility was undrawn, and we had no commercial paper
outstanding.
Long-term debt
In April 2022, we retired $500 million of maturing debt.
11

-- 11 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Long-term debt outstanding is as follows:
March 31, 	December 31,
2022 	2021
Notes due 2022 at 1.85% 	$ 	500 $ 	500
Notes due 2023 at 2.25% 	500 	500
Notes due 2024 at 2.625% 	300 	300
Notes due 2025 at 1.375% 	750 	750
Notes due 2026 at 1.125% 	500 	500
Notes due 2027 at 2.90% 	500 	500
Notes due 2029 at 2.25% 	750 	750
Notes due 2030 at 1.75% 	750 	750
Notes due 2031 at 1.90% 	500 	500
Notes due 2039 at 3.875% 	750 	750
Notes due 2048 at 4.15% 	1,500 	1,500
Notes due 2051 at 2.70% 	500 	500
Total debt 	7,800 	7,800
Net unamortized discounts, premiums and issuance costs 	(58) 	(59)
Total debt, including net unamortized discounts, premiums and issuance costs 	7,742 	7,741
Current portion of long-term debt 	(500) 	(500)
Long-term debt 	$ 	7,242 $ 	7,241
Interest and debt expense was $52 million and $46 million for the first quarters of 2022 and 2021, respectively. This was net of the amortized
discounts, premiums and issuance costs. Capitalized interest was not material.
7. Stockholders’ equity
Changes in equity are as follows:
Common Stock Paid-in Capital Retained
Earnings Treasury
Common Stock 	AOCI
Balance, December 31, 2021 	$ 	1,741 $ 	2,630 $ 	45,919 $ 	(36,800) $ 	(157)
2022
Net income 	— 	— 	2,201 	— 	—
Dividends declared and paid ($1.15 per share) 	— 	— 	(1,063) 	— 	—
Common stock issued for stock-based awards 	— 	(36) 	— 	93 	—
Stock repurchases 	— 	— 	— 	(584) 	—
Stock compensation 	— 	74 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	4
Dividend equivalents on RSUs 	— 	— 	(5) 	— 	—
Other 	— 	(1) 	1 	— 	—
Balance, March 31, 2022 	$ 	1,741 $ 	2,667 $ 	47,053 $ 	(37,291) $ 	(153)
12

-- 12 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Common Stock Paid-in Capital Retained
Earnings
Treasury
Common Stock 	AOCI
Balance, December 31, 2020 	$ 	1,741 $ 	2,333 $ 	42,051 $ 	(36,578) $ 	(360)
2021
Net income 	— 	— 	1,753 	— 	—
Dividends declared and paid ($1.02 per share) 	— 	— 	(940) 	— 	—
Common stock issued for stock-based awards 	— 	(3) 	— 	199 	—
Stock repurchases 	— 	— 	— 	(100) 	—
Stock compensation 	— 	61 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	13
Dividend equivalents on RSUs 	— 	— 	(4) 	— 	—
Balance, March 31, 2021 	$ 	1,741 $ 	2,391 $ 	42,860 $ 	(36,479) $ 	(347)
8. Contingencies
Indemnification guarantees
We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal,
infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.
Warranty costs/product liabilities
We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have
been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of
payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a
material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate
us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of
our products.
General
We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we
believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or
liquidity.
9. Supplemental financial information
Restructuring charges/other
During the first quarter of 2022, restructuring charges/other included $66 million related to integration charges at our Lehi, Utah,
manufacturing facility. These costs are included in Other for segment reporting purposes.
13

-- 13 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income
Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the first quarters
of 2022 and 2021. The table below details where these transactions are recorded in our Consolidated Statements of Income.
For Three Months Ended
Impact to Related Statement of Income
Lines
March 31,
2022 	2021
Net actuarial losses of defined benefit plans:
Recognized net actuarial loss and settlement losses (a) 	$ 	3 $ 	11 Decrease to OI&E
Tax effect 	(1) 	(3)
Decrease to provision for income
taxes
Recognized within net income, net of taxes 	$ 	2 $ 	8 Decrease to net income
(a) Detailed in Note 5.
Stock compensation
During the first quarter of 2022, 1 million shares were issued from treasury related to stock compensation.
14

-- 14 of 28 --

ITEM 2. Management’s discussion and analysis of financial condition and results of operations
Overview
We design, make and sell semiconductors to electronics designers and manufacturers all over the world. Technology is the foundation of our
company, but ultimately, our objective and the best metric to measure progress and generate long-term value for owners is the growth of free
cash flow per share.
Our strategy to maximize free cash flow per share growth has three elements:
1. A great business model that is focused on analog and embedded processing products and built around four sustainable competitive
advantages. The four sustainable competitive advantages are powerful in combination and provide tangible benefits:
i. A strong foundation of manufacturing and technology that provides lower costs and greater control of our supply chain.
ii. A broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for
our investments.
iii. The reach of our market channels that gives access to more customers and more of their design projects, leading to the
opportunity to sell more of our products into each design and gives us better insight and knowledge of customer needs.
iv. Diversity and longevity of our products, markets and customer positions that provide less single point dependency and longer
returns on our investments.
Together, these competitive advantages help position TI in a unique class of companies capable of generating and returning
significant amounts of cash for our owners. We make our investments with an eye towards long-term strengthening and leveraging of
these advantages.
2. Discipline in allocating capital to the best opportunities. This spans how we select R&D projects, develop new capabilities like
TI.com, invest in new manufacturing capacity or how we think about acquisitions and returning cash to our owners.
3. Efficiency, which means constantly striving for more output for every dollar spent.
We believe that our business model with the combined effect of our four competitive advantages sets TI apart from our peers and will for a
long time to come. We will invest to strengthen our competitive advantages, be disciplined in capital allocation and stay diligent in our pursuit
of efficiencies. Finally, we will remain focused on the belief that long-term growth of free cash flow per share is the ultimate measure to
generate value.
Management’s discussion and analysis of financial condition and results of operations (MD&A) should be read in conjunction with the
financial statements and the related notes that appear elsewhere in this document. In the following discussion of our results of operations:
• Our segments represent groups of similar products that are combined on the basis of similar design and development requirements,
product characteristics, manufacturing processes and distribution channels, and how management allocates resources and measures
results. See Note 1 to the financial statements for more information regarding our segments.
• When we discuss our results:
◦ Unless otherwise noted, changes in our revenue are attributable to changes in customer demand, which are evidenced by
fluctuations in shipment volumes.
◦ New products do not tend to have a significant impact on our revenue in any given period because we sell such a large
number of products.
◦ From time to time, our revenue and gross profit are affected by changes in demand for higher-priced or lower-priced
products, which we refer to as changes in the “mix” of products shipped.
15

-- 15 of 28 --

◦ Because we own much of our manufacturing capacity, a significant portion of our operating cost is fixed. When factory
loadings decrease, our fixed costs are spread over reduced output and, absent other circumstances, our profit margins
decrease. Conversely, as factory loadings increase, our fixed costs are spread over increased output and, absent other
circumstances, our profit margins increase.
• For an explanation of free cash flow and the term “annual operating tax rate,” see the Non-GAAP financial information section.
• All dollar amounts in the tables are stated in millions of U.S. dollars.
The coronavirus (COVID-19) pandemic and its effects are impacting and will likely continue to impact market conditions and business
operations across industries worldwide, including at TI. Therefore, we remain cautious about how the economy might behave for the next few
years and continue to monitor potential impact on our operations.
Performance summary
Our first quarter revenue was $4.91 billion, net income was $2.20 billion and earnings per share (EPS) were $2.35.
Revenue increased 14% from the same quarter a year ago primarily due to growth in industrial and automotive.
Our cash flow from operations of $9.1 billion for the trailing 12 months again underscored the strength of our business model. Free cash flow
for the same period was $6.5 billion and 34% of revenue. This reflects the quality of our product portfolio, as well as the efficiency of our
manufacturing strategy, including the benefit of 300-millimeter production.
Over the past 12 months we invested $3.2 billion in R&D and SG&A, invested $2.6 billion in capital expenditures and returned $5.0 billion to
shareholders.
Results of operations – first quarter 2022 compared with first quarter 2021
Revenue of $4.91 billion increased $616 million, or 14%, primarily due to higher revenue from Analog and, to a lesser extent, Embedded
Processing. This increase benefited from higher prices and the mix of products shipped.
Gross profit of $3.44 billion was up $645 million, or 23%, primarily due to higher revenue. As a percentage of revenue, gross profit increased
to 70.2% from 65.2%.
Operating expenses (R&D and SG&A) were $813 million compared with $811 million.
Restructuring charges/other was $66 million due to integration charges at our Lehi, Utah, manufacturing facility.
Operating profit was $2.56 billion, or 52.3% of revenue, compared with $1.94 billion, or 45.2% of revenue.
OI&E was $15 million of income compared with $46 million of income.
Our provision for income taxes was $325 million compared with $186 million. This increase was due to higher income before income taxes
and lower discrete tax benefits. Our annual operating tax rate, which does not include discrete tax items, was 14% in both periods. We use
“annual operating tax rate” to describe the estimated annual effective tax rate, which differs from the 21% U.S. statutory corporate tax rate
due to the effect of U.S. tax benefits.
Net income was $2.20 billion compared with $1.75 billion. EPS was $2.35 compared with $1.87.
16

-- 16 of 28 --

First quarter 2022 segment results
Our segment results compared with the year-ago quarter are as follows:
Analog (includes Power and Signal Chain product lines)
Q1 2022 	Q1 2021 	Change
Revenue 	$ 	3,816 	$ 	3,280 	16 %
Operating profit 	2,150 	1,646 	31 %
Operating profit % of revenue 	56.3 % 	50.2 %
Analog revenue increased in both product lines, led by Signal Chain. Operating profit increased primarily due to higher revenue and
associated gross profit.
Embedded Processing (includes microcontrollers and processors)
Q1 2022 	Q1 2021 	Change
Revenue 	$ 	782 	$ 	767 	2 %
Operating profit 	315 	287 	10 %
Operating profit % of revenue 	40.3 % 	37.4 %
Embedded Processing revenue increased. Operating profit increased primarily due to higher gross profit.
Other (includes DLP products, calculators and custom ASIC products)
Q1 2022 	Q1 2021 	Change
Revenue 	$ 	307 	$ 	242 	27 %
Operating profit* 	98 	6 	1,533 %
Operating profit % of revenue 	31.9 % 	2.5 %
* Includes acquisition charges and restructuring charges/other
Other revenue increased $65 million, and operating profit increased $92 million.
Financial condition
At the end of the first quarter of 2022, total cash (cash and cash equivalents plus short-term investments) was $9.83 billion, an increase of
$86 million from the end of 2021.
Accounts receivable were $1.80 billion, an increase of $94 million compared with the end of 2021. Days sales outstanding for the first quarter
of 2022 were 33 compared with 32 at the end of 2021.
Inventory was $2.06 billion, an increase of $150 million from the end of 2021. Days of inventory for the first quarter of 2022 were 127
compared with 116 at the end of 2021.
Liquidity and capital resources
Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term
investments and access to debt markets. We also have a variable rate, revolving credit facility. As of March 31, 2022, our credit facility was
undrawn, and we had no commercial paper outstanding. Cash flows from operating activities for the first three months of 2022 were
$2.14 billion, an increase of $294 million from the year-ago period due to higher net income, partially offset by higher cash used for working
capital.
®
17

-- 17 of 28 --

Investing activities for the first three months of 2022 used $1.67 billion compared with $1.11 billion in the year-ago period. Capital
expenditures were $443 million compared with $308 million in the year-ago period and were primarily for semiconductor manufacturing
equipment and facilities in both periods. As we continue to invest to strengthen our competitive advantage in manufacturing and technology
as part of our long-term capacity planning, we expect our capital expenditures to be higher than historical levels. Short-term investments
used cash of $1.21 billion compared with $782 million in the year-ago period.
Financing activities for the first three months of 2022 used $1.60 billion compared with $1.41 billion in the year-ago period. In the year-ago
period, we retired maturing debt of $550 million. Dividends paid were $1.06 billion compared with $940 million in the year-ago period,
reflecting an increased dividend rate. We used $589 million to repurchase 3.4 million shares of our common stock compared with
$100 million used in the year-ago period to repurchase 0.6 million shares. Employee exercises of stock options provided cash proceeds of
$57 million compared with $196 million in the year-ago period.
In April 2022, we used cash and cash equivalents to retire $500 million of maturing debt.
We had $3.51 billion of cash and cash equivalents and $6.32 billion of short-term investments as of March 31, 2022. We believe we have the
necessary financial resources and operating plans to fund our working capital needs, capital expenditures, dividend and debt-related
payments, and other business requirements for at least the next 12 months.
Non-GAAP financial information
This MD&A includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in
accordance with generally accepted accounting principles in the United States (GAAP). Free cash flow was calculated by subtracting capital
expenditures from the most directly comparable GAAP measure, cash flows from operating activities (also referred to as cash flow from
operations).
We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of
cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are
supplemental to the comparable GAAP measures.
Reconciliation to the most directly comparable GAAP measures is provided in the table below.
For 12 Months Ended
March 31,
2022 	2021 	Change
Cash flow from operations (GAAP) 	$ 	9,050 	$ 	7,138 	27 %
Capital expenditures 	(2,597) 	(796)
Free cash flow (non-GAAP) 	$ 	6,453 	$ 	6,342 	2 %
Revenue 	$ 	18,960 	$ 	15,421
Cash flow from operations as a percentage of revenue (GAAP) 	47.7 % 	46.3 %
Free cash flow as a percentage of revenue (non-GAAP) 	34.0 % 	41.1 %
This MD&A also includes references to an annual operating tax rate, a non-GAAP term we use to describe the estimated annual effective tax
rate, a GAAP measure that by definition does not include discrete tax items. We believe the term annual operating tax rate helps differentiate
from the effective tax rate, which includes discrete tax items.
18

-- 18 of 28 --

ITEM 4. Controls and procedures
An evaluation as of the end of the period covered by this report was carried out under the supervision and with the participation of
management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based upon
that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that those disclosure controls and procedures were
effective. In addition, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f)
under the Securities Exchange Act of 1934) that occurred during the period covered by this report that has materially affected, or is
reasonably likely to materially affect, our internal control over financial reporting.
19

-- 19 of 28 --

PART II – OTHER INFORMATION
ITEM 1A. Risk factors
Information concerning our risk factors is contained in Item 1A of our Form 10-K for the year ended December 31, 2021, and is incorporated
by reference herein.
ITEM 2. Unregistered sales of equity securities and use of proceeds
The following table contains information regarding our purchases of our common stock during the quarter.
ISSUER PURCHASES OF EQUITY SECURITIES
Period Total Number of Shares
Purchased
Average Price
Paid per Share
Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs (a)
Approximate Dollar Value
of Shares that May Yet Be
Purchased Under the Plans
or Programs (a)
January 1, 2022 through January 31, 2022 	825,670 	$ 178.96 	576,617 	$ 10.00 billion
February 1, 2022 through February 28, 2022 	1,648,091 	168.70 	1,648,091 	9.72 billion
March 1, 2022 through March 31, 2022 	1,184,279 	171.21 	1,184,279 	9.52 billion
Total 	3,658,040 (b) 	$ 171.83 (b) 	3,408,987 	$ 	9.52 billion (c)
(a) All open-market purchases during the quarter were made under the authorization from our board of directors to purchase up to $12.0
billion of additional shares of TI common stock announced September 20, 2018.
(b) In addition to open-market purchases, 249,053 shares of common stock were surrendered by employees to satisfy tax withholding
obligations in connection with the vesting of restricted stock units.
(c) As of March 31, 2022, this amount consisted of the remaining portion of the $12.0 billion authorized in September 2018. No expiration
date has been specified for this authorization.
ITEM 5. Other information
Section 13(r) of the Securities Exchange Act of 1934 disclosure
During the period covered by this report and as set forth in General License 1B from the U.S. Office of Foreign Assets Control, we
periodically filed notifications with the Russian Federal Security Service (FSB) solely to permit the import, distribution and use of certain of
our catalog semiconductor products in Russia. No gross revenue or net profit was directly attributable to these notifications to the FSB, and
we may continue such notifications as required.
20

-- 20 of 28 --

ITEM 6. Exhibits
Designation of Exhibits in
This Report 	Description of Exhibit
3(a) Restated Certificate of Incorporation of the Registrant, dated April 18, 1985, as amended (incorporated by reference
to Exhibit 3(a) of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2014).
3(b) By-Laws of the Registrant (incorporated by reference to Exhibit 3 of the Registrant’s Current Report on Form 8-K
filed January 26, 2022).
31(a) 	Certification of Chief Executive Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
31(b) 	Certification of Chief Financial Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
32(a) 	Certification by Chief Executive Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
32(b) 	Certification by Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
101.ins XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL
tags are embedded within the Inline XBRL document.†
101.def 	XBRL Taxonomy Extension Definition Linkbase Document.†
101.sch 	XBRL Taxonomy Extension Schema Document.†
101.cal 	XBRL Taxonomy Extension Calculation Linkbase Document.†
101.lab 	XBRL Taxonomy Extension Label Linkbase Document.†
101.pre 	XBRL Taxonomy Extension Presentation Linkbase Document.†
104 	Cover Page Interactive Data File (embedded within the Inline XBRL document).†
† Filed or furnished herewith.
21

-- 21 of 28 --

Notice regarding forward-looking statements
This report includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management
“believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements
herein that describe TI’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in
forward-looking statements.
We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI
or our management:
• The duration and scope of the COVID-19 pandemic, government and other third-party responses to it and the consequences for the
global economy, including to our business and the businesses of our suppliers, customers and distributors;
• Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate,
including global trade policies;
• Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from
forecasts;
• Our ability to compete in products and prices in an intensely competitive industry;
• Evolving cybersecurity and other threats relating to our information technology systems or those of our customers, vendors and other
third parties;
• Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to
realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;
• Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, our timely
implementation of new manufacturing technologies and installation of manufacturing equipment, and our ability to realize expected
returns on significant investments in manufacturing capacity;
• Availability and cost of raw materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing
technology;
• Product liability, warranty or other claims relating to our products, software, manufacturing, delivery, services, design or
communications, or recalls by our customers for a product containing one of our parts;
• Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of
enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;
• Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are
determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax
assets;
• Financial difficulties of our distributors or semiconductor distributors’ promotion of competing product lines to our detriment; or
disputes with current or former distributors;
• Losses or curtailments of purchases from key customers or the timing and amount of customer inventory adjustments;
• Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover
our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;
• Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where
we conduct business; or our exposure to infringement claims;
• Instability in the global credit and financial markets;
• Our ability to recruit and retain skilled personnel, and effectively manage key employee succession; and
22

-- 22 of 28 --

• Impairments of our non-financial assets.
For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of our most recent Form 10-K. The forward-
looking statements included in this report are made only as of the date of this report, and we undertake no obligation to update the forward-
looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that
we will make additional updates with respect to that statement or any other forward-looking statement.
23

-- 23 of 28 --

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
TEXAS INSTRUMENTS INCORPORATED
By: 	/s/ Rafael R. Lizardi
Rafael R. Lizardi, Senior Vice President and Chief
Financial Officer
Date: April 27, 2022

-- 24 of 28 --

Exhibit 31(a)
CERTIFICATIONS
I, Richard K. Templeton, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-
15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.
Date: April 27, 2022
/s/ Richard K. Templeton
Richard K. Templeton
Chairman, President
and Chief Executive Officer

-- 25 of 28 --

Exhibit 31(b)
CERTIFICATIONS
I, Rafael R. Lizardi, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-
15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.
Date: April 27, 2022
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 26 of 28 --

Exhibit 32(a)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Richard K.
Templeton, the Chairman, President and Chief Executive Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his
knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission
on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 27, 2022
/s/ Richard K. Templeton
Richard K. Templeton
Chairman, President
and Chief Executive Officer

-- 27 of 28 --

Exhibit 32(b)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Rafael R. Lizardi,
Senior Vice President and Chief Financial Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission
on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 27, 2022
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 28 of 28 --